PloS one · 2026
Reliability of tachycardia as an early warning sign in acute clozapine-induced cardiac inflammation: Protocol for a systematic review.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
O'Neill James Richard, Prasad Prakruti Babu Narendra, Croft Matthew, Manton Matthew, King Natalie, Romeu Daniel
Аннотация
INTRODUCTION: Clozapine-induced cardiac inflammation (CICI) can have serious consequences for people with psychosis and can be fatal if not detected in a timely manner. The best available methods of investigation for CICI are resource-intensive, whereas clinical practice often utilises cheaper and more practical methods of detection such as history, examination, and blood tests. Heart rate monitoring is commonly used as an early-warning sign in detecting potential CICI. Previous studies have found that, although this has a high sensitivity, it has poor specificity. As far as we are aware, no systematic review has investigated the role of tachycardia as a detection tool for CICI.
METHODS AND ANALYSIS: Systematic diagnostic test accuracy review of the available literature will be used to assess the effectiveness of tachycardia as an early-warning sign for CICI. We will search eight electronic databases and grey literature using a comprehensive and systematic approach. Grey literature sources will include conference proceedings and professional guidance documents identified through expert consultations. Retrieved articles will be critically appraised, synthesised, and meta-analysed, where data permit.
ETHICS AND DISSEMINATION: This systematic review will use data from existing studies, hence no ethical approvals are required. Findings will be disseminated to academic colleagues through a peer-reviewed publication and relevant academic meetings, and to clinicians through distribution to local and national clinical networks. PROSPERO registration ID: CRD42025650379.
METHODS AND ANALYSIS: Systematic diagnostic test accuracy review of the available literature will be used to assess the effectiveness of tachycardia as an early-warning sign for CICI. We will search eight electronic databases and grey literature using a comprehensive and systematic approach. Grey literature sources will include conference proceedings and professional guidance documents identified through expert consultations. Retrieved articles will be critically appraised, synthesised, and meta-analysed, where data permit.
ETHICS AND DISSEMINATION: This systematic review will use data from existing studies, hence no ethical approvals are required. Findings will be disseminated to academic colleagues through a peer-reviewed publication and relevant academic meetings, and to clinicians through distribution to local and national clinical networks. PROSPERO registration ID: CRD42025650379.